Skip to content
Health Horizon

Health Horizon

Healthy Body Your Time in Health

Primary Menu Health Horizon

Health Horizon

  • Health Horizon
  • Health Technology Innovation
  • Global Health and the Health Crisis
  • Mental Health and Emotional Wellbeing
  • Genetics and Gene Therapy Research
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
Flash Story
CDC in Nigeria | Global Health CDC in Nigeria | Global Health Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News Global Health Updates: US & WHO News Global Health Updates: US & WHO News Unlocking the Potential of Gene Therapy for Genetic Skin Disorders Unlocking the Potential of Gene Therapy for Genetic Skin Disorders Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Main Story

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0

Editor’s Picks

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0

Trending Story

CDC in Nigeria | Global Health
1
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
2
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

Global Health Updates: US & WHO News
3
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
4
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
5
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Featured Story

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0

Key accomplishments Helped the Nigerian government establish an automated biometric identification system within the National Data Repository to support HIV...

Read MoreRead more about CDC in Nigeria | Global Health
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0

New Delhi: Even as some Delhi schools roll out structured lessons on emotional wellbeing under the Science of Living curriculum...

Read MoreRead more about Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0

Unpacking Global Health: A Look at US and WHO News, Guys! What’s the latest buzz in the world of health,...

Read MoreRead more about Global Health Updates: US & WHO News
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0

Original story from the University of British Columbia (British Columbia, Canada). Gene-editing tools like CRISPR have unlocked new treatments for...

Read MoreRead more about Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0

Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study...

Read MoreRead more about Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
Conflict and instability make pregnancy more dangerous
  • Global Health and the Health Crisis

Conflict and instability make pregnancy more dangerous

admin February 20, 2026 0

Nearly two-thirds of all maternal deaths worldwide occur in countries marked by conflict or fragility. The maternal mortality ratio of a woman who lives...

Read MoreRead more about Conflict and instability make pregnancy more dangerous
Local hospital CEOs aren’t needed: top Horizon official
  • Health Horizon

Local hospital CEOs aren’t needed: top Horizon official

admin February 20, 2026 0

Breadcrumb Trail LinksNew BrunswickNewsThe IssuesHealth careOpposition MLAs continue call for local CEOs to address hospital woesPublished Feb 18, 2026  • ...

Read MoreRead more about Local hospital CEOs aren’t needed: top Horizon official
Australia Air Purifier Market: Indoor Air Quality, Health Awareness & Technology Innovation
  • Health Technology Innovation

Australia Air Purifier Market: Indoor Air Quality, Health Awareness & Technology Innovation

admin February 20, 2026 0

According to IMARC Group, the Australia air purifier market was valued at USD 438.89 Million in 2025 and is projected...

Read MoreRead more about Australia Air Purifier Market: Indoor Air Quality, Health Awareness & Technology Innovation
Gene therapy for blindness and vision loss gains momentum
  • Genetics and Gene Therapy Research

Gene therapy for blindness and vision loss gains momentum

admin February 19, 2026 0

Since the approval of the first-ever gene therapy for blindness, there has been a wave of biotechs developing gene therapy...

Read MoreRead more about Gene therapy for blindness and vision loss gains momentum

Posts pagination

1 2 3 4 … 163 Next

Recent Posts

  • CDC in Nigeria | Global Health
  • Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Global Health Updates: US & WHO News
  • Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023

Categories

  • Genetics and Gene Therapy Research
  • Global Health and the Health Crisis
  • Health Horizon
  • Health Technology Innovation
  • Mental Health and Emotional Wellbeing
  • News

Visit Us

Core Medicalcare

You may have missed

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.